An experienced leader in corporate development and operations steps into new role at growing start-up SAN DIEGO- November 20, 2020- Omniome, Inc., developer of an innovative DNA sequencing platform capable of delivering unsurpassed sequencing accuracy, announces the promotion of Kelly Perez to Chief Operating Officer. Kelly, who has been Senior Vice President, Finance & Operations […]
ST. LOUIS, MO. — PierianDx, the global leader in clinical genomics knowledge, today announced the appointment of Lindsay Mateo as Chief Business Officer, effective immediately. In her new role, Ms. Mateo will reinforce the company’s position as the leading provider of clinical genomics solutions in the fight against cancer and hereditary disease. She will also head […]
The Nomination Committee proposes that Genovis should expand its Board of Directors at the 2021 Annual General Meeting and proposes Steve Jordan to be elected as a new board member. Steve Jordan was born in 1953 and resides in the United Kingdom. He is currently working as a consultant for several companies engaged in development […]
Jon Kratochvil joins as Vice President for Business Development & Licensing for North America DUBLIN, Ireland, 01 March 2021: ERS Genomics Limited (“ERS”), which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, today announced the appointment of Jon Kratochvil as Vice-President for Business Development & Licensing for […]
Company adds two directors with financial, pharmaceutical, and consumable business expertise BOSTON — 908 Devices Inc. (NASDAQ: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced it has appointed Jeff George and Fenel Eloi to serve on its Board of Directors, effective immediately. Mr. George brings more than two decades of global […]
CAMBRIDGE, UK: Optibrium™, a developer of software for drug discovery, today announced the appointment of Dr Rae Lawrence as Director of Software Development. With the continued success of the Company’s portfolio of cheminformatics and AI-based drug discovery software, and the recent backing by Kester Capital, Optibrium has made the new appointment to drive its product development […]
Thomas Ebeling appointed to the Supervisory Board Venlo, the Netherlands – QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today the appointment of Thomas Ebeling, a leading international executive with extensive experience in the healthcare, media and consumer goods industries, as a member of the Supervisory Board with immediate effect. Mr. Ebeling joins QIAGEN as part […]
Technology Visionary will Offer Strategic Insight to Guide Ongoing Research & Development of Market Leading Organ-on-a-Chip Technology BOSTON, Mass. – Emulate, Inc., a leading provider of organ-on-a-chip technology today announced the appointment of Donald Ingber, M.D., Ph.D., to its Board of Directors. Ingber, the scientific founder of Emulate and Chairman of its Scientific Advisory Board […]
Company adds two directors with experience in building and growing transformative companies REDWOOD CITY, Calif. — Seer, Inc., (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it has appointed Deep Nishar and Mostafa Ronaghi, Ph.D. to serve on its Board of Directors, effective February 13, 2020. Mr. Nishar […]
Ultivue announces the addition of new executive team members in order to help strengthen its position as a leading assay development solutions provider for multiplex biomarker analysis for tissue phenotyping. Mike Sismour, PhD has joined Ultivue in the role of Vice President, Research, and Mark Rees, PhD has joined as Vice President, Corporate Development. Mike has a […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
